“…The combined search strategies identified 29 trials [6,9,10,11,12,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38], including 2,763 patients (1,051 tamsulosin 0.4 mg/day, 145 tamsulosin 0.2 mg/day and 1,567 controls), that met the inclusion criteria. One of the studies was written in Korean [26] and another in Chinese [38].…”